TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
DON'T BUY

He has not been a fan of this company. Its numbers keep coming out of nowhere, and you get blindsided. A very unpredictable situation. Also, doesn’t like that they are so dependent on far eastern growth. Feels that any significant investment in China is high risk.

COMMENT

Chart shows a little bit of base building which is positive, but it has to hurdle over the downtrend line. On a chart like this, it can break down either way. The odds are that it does kind of move up to get up to something a little bit higher. It looks like it wants to migrate up to the $22-$23 level. The technical target, 1st resistance, is around $24.

PAST TOP PICK

(Top Pick Jun 4/15, Down 13.63%) He got out due to a stop loss. The insurance group is showing strength but he would prefer SLF-T.

HOLD

Has had a number of issues in the past, especially with their US investments. Have fixed some of the issues so it is now a better managed company. Wouldn’t consider this as “Best in class”, but more or less in the middle of the pack. Their Japanese operations are very good.

DON'T BUY

This is going to be really dependent on where interest rates are moving. If they start moving higher, this stock should start moving higher. He prefers Sun Life (SLF-T) which has performed better and has a bit more diversification. However, this one is fine longer-term. Given that the 200 day moving average is falling, it is not a name he would own.

HOLD

Share price performance has been disappointing. Had some headwinds in their investment portfolios through their energy exposure. She likes their position in Asia which gives him about 32% of their revenue. It is trading at 1X Price to BV. Longer-term this will have a higher core earnings growth profile. Dividend yield of about 4%.

SELL

This has very strong seasonality. Normally from around the end of January to the end of May the stock has gone up. Recently the stock has been going sideways, and slightly underperforming the market. We are getting close to the end of May and the technicals are starting to roll over a little. There are better opportunities to invest in other than this one. You want to sell into strength in the next couple of weeks.

COMMENT

A little cheaper than Sun Life (SLF-T). The whole industry requires higher interest rates to get moving. They delivered a bit of a surprise over the last 6 months in that they have investments in energy, and the stock pulled back. If you are a patient investor, you will do very well in both stocks. ROE is sub 10. Sun Life has a better ROE. They both have great Asian exposure which is doing well. Canadian banks will do better than either.

SELL

Sell or hold? This has been a tough one, and every quarter there are so many reasons that the shares should go up, and they just haven’t. They moved their business to becoming more focused on wealth management, which provides reoccurring revenues. Did a great acquisition of Standard Life and picked up instant clients that they could sell more cross products to. Also, have been able to penetrate in China where 30% of revenues come from now. Look at your portfolio and see what weighting you have in financials. If you are not overweight, that money would be better served in other financials such as Canadian banks.

DON'T BUY

Canadian Banks or Lifecos. You have overhead supply. It is struggling. Prices will have a tendency to go back to the ‘backline’ about $19. Chances are that it goes a bit lower. Overhead supply is those that bought higher and are tempted to sell as it goes higher.

TOP PICK

This has become incredibly cheap at a 9.8 P/E ratio compared to a longer-term average of 10+. Lifecos need good stock markets to bring the value of their holdings up. They need higher returns from bonds. What they don’t need are bad experiences from oil/gas such as they’ve had. The business is growing like crazy in Asia and Canada, and to a lesser extent in the US.

COMMENT

This has global operations. Some of their Asian operations are very exciting where they have very rapid growth. In the last 2 weeks, interest rates in Canada have been declining which could have been the reason for some of the pressure on the shares.

TOP PICK

It has been frustrating, but he sees their earnings next year being 25% better than this year. They have been hit by their energy book, actuarial charges and lower rates. They are so much cheaper than SLF-T. The 4% dividend will grow 12% annually. Buy it on the US side if you have US cash.

DON'T BUY

This one has always had something come up and they stumble. He is warm toward the lifecos, especially as rates start to go up. He prefers SLF-T.

TOP PICK

This has pulled back, a lot like US banks. Lifecos are all exposed to interest rates, and get squeezed when rates don’t go up. This has a lot of growth in Asia that is kind of non-interest rate exposed. They also have John Hancock in the US. He is showing 9X earnings and a discount to Book forward, which is as cheap as these things get. It will go back to $21-$22. Dividend yield of 4.03%.

Showing 781 to 795 of 2,283 entries